Rhovica
Bern, SwitzerlandFounded 2023
- Neuroimaging
- Seed
Rhovica develops SoNav, a platform for advanced neurosurgical visualization and monitoring. It aims to help clinicians treat brain emergencies with greater precision by guiding procedures where they may otherwise rely on pre-acquired CT scans without direct imaging.
- RaisedTotal raised
- $3.1M
- Aug 2025Latest priced round, Aug 2025
- Seed
- Investors
- 4
- Founded
- 2023
- Employees
- 1–10
reccy insights
Rhovica’s clearest recent milestone was its selection for Venturelab’s Swiss National Medtech Team 2026, announced on Jun 24, 2026. The recognition highlights its guided neurosurgery imaging work and includes selection for the Boston Venture Leaders Medtech roadshow. Earlier in 2026, Rhovica was named a finalist for the Ypsomed Innovation Award; the award program offered CHF 100,000 in total prizes. In December 2025, the company was selected for the first phase of the sitem-insel Innovation Voucher program for its SoNav ultrasound-guided catheter system. A major financing milestone came on Aug 26, 2025, when Rhovica raised CHF 2.3 million, approximately $2.86 million, in a seed round led by M2care. At the same time, M2care Managing Director Carsten Laue joined Rhovica’s Board of Directors to support strategy and SoNav’s progress toward clinical adoption. The company also received CHF 170,000 across Venture Kick grants in 2022. Together, these milestones indicate continued support for product development and recognition within Switzerland’s medtech ecosystem; they do not establish regulatory clearance or commercial adoption.
Written by reccy's AI from company sites, press and funding records · updated Oct 2026
What makes Rhovica distinct
- 01Focuses on improving visibility and guidance during neurosurgical procedures.
- 02Targets time-critical brain emergencies, including severe trauma and brain bleeding.
- 03Aims to guide procedures that may otherwise rely on pre-acquired CT scans without direct imaging.
- 04Combines ultrasound-guided EVD placement with real-time monitoring capabilities.
Technology & products
- SoNav™ EVD Catheter
A catheter system designed for rapid and accurate placement of external ventricular drains, with integrated real-time monitoring capabilities.
- SoNav Platform for neurosurgical visualization and monitoring.
- SoNav™ EVD Catheter designed for rapid, accurate external ventricular drain placement.
- Ultrasound-guided catheter placement.
- Integrated real-time monitoring capabilities.
Recent updates4
- Jun 24, 2026Award
Swiss National Medtech Team 2026 (Venture Leader Medtech)
- Jan 22, 2026Award
Ypsomed Innovation Award 2026 finalist
- Dec 2, 2025Award
sitem-insel Innovation Voucher (Phase 1 selection)
Funding
- SeedAug 2025$2.9MLed by M2care
- GrantDec 2022$162KLed by Venture Kick
- GrantJun 2022$20KLed by Venture Kick
Similar companies
About Rhovica
- Products
- SoNav™ EVD Catheter
- Leadership
- Martin Hlavica, Co-Founder and CEO
- Focus areas
- Neurotechnology, medical devices, digital health, diagnostics, neuroimaging, neurosurgery, surgical navigation, clinical monitoring
- Headquarters
- Bern, Switzerland
- Founded
- 2023
- Employees
- 1–10
- Patents granted
- 1
- Trademarks
- 1